The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Exciting advancements in the MDS space
Ryotaro Nakamura, MD, City of Hope, Duarte, CA, gives an overview of some exciting research being conducted in the field of myelodysplastic syndromes (MDS), emphasizing the value of studies which aim to provide a better understanding of the underlying biology and heterogeneity of MDS. Dr Nakamura then comments on the promise of novel immunotherapeutic agents and treatment approaches in MDS. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
